Fig. 1.
Patient outcome and viral kinetics after NA discontinuation. (A) Patient outcome after NA discontinuation. Bars represent the percentage of patients with HBsAg loss, virological control, or re-treatment. The number of patients is shown within the bars. (B) HBV-DNA, HBsAg, and ALT kinetics. For re-treated patients, the dotted line represents the evolution after treatment re-introduction. ALT, alanine aminotransferase; NA, nucleos(t)ide analogue.